TherapeuticsMD Inc logo

TXMD - TherapeuticsMD Inc News Story

$0.305 -0.0  -2.7%

Last Trade - 9:00pm

Sector
Healthcare
Size
Small Cap
Market Cap £98.3m
Enterprise Value £158.7m
Revenue £67.0m
Position in Universe 5174th / 7405

BRIEF-TherapeuticsMD Reports Q4 And Full Year 2020 Results

Tue 2nd March, 2021 12:27pm
March 2 (Reuters) - TherapeuticsMD Inc  TXMD.O :
    * THERAPEUTICSMD ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2020
FINANCIAL RESULTS
    * Q4 LOSS PER SHARE $0.15
    * Q4 EARNINGS PER SHARE ESTIMATE $-0.11 -- REFINITIV IBES
DATA
    * FINANCING AGREEMENT AMENDED TO UPDATE MINIMUM NET REVENUE
COVENANTS FOR REMAINDER OF LOAN; TO PAY DOWN $50 MILLION IN DEBT

Source text for Eikon:  ID:nBwbd7mZJa 
Further company coverage:  TXMD.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2022, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.